To Cure Cancer: How Science and Medicine are Battling the World’s Most Deadly Disease
There is no video for this event.
Vail Symposium Super Panel
In partnership with the University of Michigan Comprehensive Cancer Center, an internationally recognized leader in researching and developing future cancer treatments, the Vail Symposium will present two sessions to explore what is being done to beat the ugly sickness that is cancer.
Dr. Theodore Lawrence, Director of the Comprehensive Cancer Center, will focus on chemotherapeutic and molecularly targeted radiosensitizers
Dr. Gary Hammer, Director of the Endocrine Oncology Program, will focus on adrenal cancer
Dr. Michael Sabel, Chief of the Division of Surgical Oncology, will focus on breast cancer and melanoma with expertise in cryoimmunology
Dr. Judy Sebolt-Leopold, Principal Investigator in the Translational Oncology Program, will focus on small molecules used for early cancer detection
Dr. Thomas Wang, a physician scientist will focus on the development of the first video endoscope to rapidly identify pre-malignant lesions
Dr. Patricia Hardenbergh, Medical Director of Radiation Oncology at the Shaw Regional Cancer Center in Edwards, will moderate the program
SESSION 1: Cancer prevention, screening and early detection
10 a.m. to noon
Cancer becomes deadly when it spreads throughout the body. That’s why University of Michigan Comprehensive Cancer Center (UMCCC) researchers are focusing on early detection. Here, UMCCC scientists will discuss the development of promising techniques to identify precancerous tissue and better tests for population-based screening. It is also known that certain genes are associated with a higher risk of cancer. UMCCC scientists will present research that is at the forefront of identifying genes and other markers that increase a person’s likelihood of developing cancer.
SESSION 2: Personalized medicine, precision targeting and immunotherapy
1 p.m. to 3 p.m.
Armed with new insights into the disordered wiring circuits of cancer cells, major technological advancements and a multidisciplinary collaborative approach, UMCCC scientists will discuss how they are on the brink of discoveries that promise to usher in an entirely new era of treatment. This session will discuss how gone are the days of looking for a “one-size-fits-all” treatment for cancer by explaining how conducting genomic analysis in patients, leveraging cutting edge DNA and RNA sequencing technologies to identify precise treatments to match their cancer “fingerprint,” harnessing the body’s own immune system to attack cancer cells without devastating side effects, new imaging techniques and precision radiation methods are changing the landscape of cancer treatment and patient wellbeing.
Event Begins at 10 a.m. and lasts until approximately 3 p.m.
Social Notes: For approximately 1 hour between the two sessions there will be a social time with lunch by Northside Kitchen where the audience can ask the doctors questions 1-on-1. Also there will be a reception after session 2 at approximately 3:00pm.